Soluble Interleukin-2 Receptor Predicts Treatment Outcome in Patients With Autoimmune Tubulointerstitial Nephritis. A Preliminary Study.
Shiratori-Aso S, Nakazawa D, Nishio S, Ueda Y, Eguchi M, Yokoyama A, Yoshikawa J, Kudo T, Watanabe-Kusunoki K, Takeda-Otera S, Yamamoto J, Matsuoka N, Kaneshima N, Hattanda F, Iwasaki S, Tsuji T, Fukasawa Y, Atsumi T.
Shiratori-Aso S, et al. Among authors: yamamoto j.
Front Med (Lausanne). 2022 Feb 25;9:827388. doi: 10.3389/fmed.2022.827388. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 35280914
Free PMC article.